Hyderabad, January 11, 2026: MedPlus Health Services Limited informed stock exchanges on Sunday that one of its subsidiary-operated pharmacy outlets in Karnataka has received a temporary suspension of its drug licence, impacting operations for a brief period.
The development relates to Optival Health Solutions Private Limited, a wholly owned subsidiary of MedPlus Health Services, which operates a pharmacy store located on S Rammurthy Road in Virajpet, Karnataka. The suspension order was received on January 10, 2026, and mandates a two-day halt in operations at the concerned outlet.
Details of the Action
The order was issued by the Assistant Director, Drugs Control Administration, Madikeri Circle, and applies specifically to the Virajpet store. The action is limited in scope and duration, with no indication of any broader impact on MedPlus’ wider store network across India.According to the company’s disclosure, the temporary suspension is expected to result in a potential revenue loss of approximately ₹0.74 lakh, which the management indicated is not material in the context of overall business operations.
Business Impact and Outlook
MedPlus stated that the matter pertains to a single store and does not affect the company’s core operations, supply chain, or service continuity across other regions. The company continues to operate its nationwide pharmacy and healthcare retail network as usual.About the Company
MedPlus Health Services Limited is a listed healthcare and pharmacy retail chain in India, operating an extensive network of stores across multiple states. The company focuses on retail pharmacy, diagnostics, and online healthcare services, catering to urban and semi-urban markets through a mix of physical and digital channels.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.